Financial Perspectives’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.8K | Hold |
517
| – | – | 0.01% | 418 |
|
|
2025
Q1 | $20K | Buy |
517
+3
| +0.6% | +$116 | 0.01% | 414 |
|
|
2024
Q4 | $17.4K | Buy |
514
+2
| +0.4% | +$68 | 0.01% | 429 |
|
|
2024
Q3 | $20.9K | Buy |
512
+2
| +0.4% | +$82 | 0.01% | 385 |
|
|
2024
Q2 | $19.6K | Buy |
510
+2
| +0.4% | +$77 | 0.01% | 386 |
|
|
2024
Q1 | $21.8K | Buy |
508
+2
| +0.4% | +$86 | 0.01% | 369 |
|
|
2023
Q4 | $18.7K | Buy |
506
+2
| +0.4% | +$74 | 0.01% | 386 |
|
|
2023
Q3 | $18.3K | Buy |
504
+3
| +0.6% | +$109 | 0.01% | 369 |
|
|
2023
Q2 | $17.9K | Buy |
501
+2
| +0.4% | +$71 | 0.01% | 376 |
|
|
2023
Q1 | $17.8K | Buy |
499
+1
| +0.2% | +$36 | 0.01% | 373 |
|
|
2022
Q4 | $17.5K | Buy |
498
+3
| +0.6% | +$105 | 0.01% | 375 |
|
|
2022
Q3 | $14.6K | Hold |
495
| – | – | 0.01% | 391 |
|
|
2022
Q2 | $26.9K | Buy |
495
+3
| +0.6% | +$163 | 0.02% | 309 |
|
|
2022
Q1 | $26.8K | Buy |
492
+2
| +0.4% | +$109 | 0.01% | 328 |
|
|
2021
Q4 | $27K | Buy |
490
+3
| +0.6% | +$165 | 0.01% | 321 |
|
|
2021
Q3 | $23.3K | Sell |
487
-4,958
| -91% | -$237K | 0.01% | 339 |
|
|
2021
Q2 | $271K | Sell |
5,445
-188,757
| -97% | -$9.39M | 0.13% | 105 |
|
|
2021
Q1 | $6.8M | Buy |
194,202
+188,763
| +3,471% | +$6.61M | 0.34% | 50 |
|
|
2020
Q4 | $250K | Sell |
5,439
-1,597
| -23% | -$73.5K | 0.14% | 102 |
|
|
2020
Q3 | $331K | Buy |
7,036
+2
| +0% | +$94 | 0.22% | 66 |
|
|
2020
Q2 | $359K | Buy |
7,034
+3
| +0% | +$153 | 0.26% | 57 |
|
|
2020
Q1 | $333K | Buy |
7,031
+1
| +0% | +$47 | 0.27% | 49 |
|
|
2019
Q4 | $413K | Buy |
+7,030
| New | +$413K | 0.28% | 45 |
|